# The Prognostic Value of Tertiary Lymphatic Structure in Esophageal Squamous Cell Carcinoma

> **NCT06241066** · — · COMPLETED · sponsor: **Tianjin Medical University Cancer Institute and Hospital** · enrollment: 359 (actual)

## Conditions studied

- Esophageal Squamous Cell Carcinoma

## Interventions

- **OTHER:** no-Intervention

## Key facts

- **NCT ID:** NCT06241066
- **Lead sponsor:** Tianjin Medical University Cancer Institute and Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01-01
- **Primary completion:** 2023-10-31
- **Final completion:** 2023-10-31
- **Target enrollment:** 359 (ACTUAL)
- **Last updated:** 2024-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06241066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06241066, "The Prognostic Value of Tertiary Lymphatic Structure in Esophageal Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06241066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*